Quick Answer
GE HealthCare Technologies Inc. reported Diluted EPS of $4.55 per share for fiscal year 2025.
GE HealthCare Technologies Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $4.55 | +4.8% |
| 2024 | $4.34 | +43.2% |
| 2023 | $3.03 | -28.2% |
| 2022 | $4.22 | -14.7% |
| 2021 | $4.95 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.98 | -3.9% | -7.5% |
| June 30, 2025 | $1.06 | +14.0% | -13.8% |
| March 31, 2025 | $1.23 | +51.9% | +20.6% |
| September 30, 2024 | $1.02 | +24.4% | +9.7% |
| June 30, 2024 | $0.93 | +2.2% | +14.8% |
| March 31, 2024 | $0.81 | +97.6% | -1.2% |
| September 30, 2023 | $0.82 | -23.4% | -9.9% |
| June 30, 2023 | $0.91 | -15.0% | +122.0% |
- GE HealthCare Technologies Inc. showed an increase of +4.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, GE HealthCare Technologies Inc.’s diluted eps has declined by 8.1% (from $4.95 per share to $4.55 per share).
- The most recent figure is from GE HealthCare Technologies Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: